Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topographic Differences in Superficial Macular Vessel Density in Eyes with Early Primary Open-Angle Glaucoma and Normal Tension Glaucoma.

Ophthalmic research·2023
Same author

Clinical implication of recent randomized control trial in primary angle-closure disease management.

Indian journal of ophthalmology·2022
Same author

Retinal nerve fiber layer thickness in amblyopia.

Indian journal of ophthalmology·2022
Same author

Five-year incidence of primary glaucoma and related risk factors - The Handan eye study.

Acta ophthalmologica·2022
Same author

Progression rate to primary angle closure following laser peripheral iridotomy in primary angle-closure suspects: a randomised study.

International journal of ophthalmology·2021
Same author

Association of Hypertriglyceridemia and Incident Glaucoma in a Rural Chinese Population: The Handan Eye Study.

Translational vision science & technology·2021
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Related Experiment Videos

Clear lens extraction in angle closure glaucoma.

Ravi Thomas1, Mark J Walland, Rajul S Parikh

  • 1Queensland Eye Institute, South Brisbane, Queensland, Australia. ravi.thomas@qei.org.au

Current Opinion in Ophthalmology
|December 31, 2010
PubMed
Summary
This summary is machine-generated.

Clear lens extraction (CLE) lacks robust evidence for primary angle closure disease (PACD). While potentially beneficial, current research is sparse, necessitating careful risk-benefit assessment before widespread adoption.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Interventions

Background:

  • Primary angle closure disease (PACD) management is evolving.
  • Clear lens extraction (CLE) is increasingly advocated for PACD.
  • A strong evidence base is crucial for clinical adoption.

Purpose of the Study:

  • To evaluate the existing evidence for CLE in PACD.
  • To determine the extent of peer-reviewed support for CLE in PACD.
  • To provide preliminary management guidelines based on current evidence.

Main Methods:

  • Systematic review of published reports on CLE for angle closure.
  • Analysis of existing randomized controlled trials (RCTs) and Cochrane reviews.
  • Extrapolation of evidence from cataract extraction studies.

Main Results:

  • Only three reports detail CLE for angle closure; data is limited.
  • No studies compare modern phacoemulsification CLE to alternative treatments for PACG.
  • Recent RCTs support cataract extraction (not specifically CLE) for some PACD cases.

Conclusions:

  • Currently, no RCTs specifically support CLE for primary angle closure glaucoma (PACG).
  • A theoretical benefit of CLE in PACG is plausible.
  • Evidence extrapolation may guide select cases, but risks must be weighed against benefits.